BOIRON SA
BOIRON SA
Share · FR0000061129 · 873532 (XPAR)
Overview
No Price
Closing Price XPAR 04.02.2026: 29,80 EUR
04.02.2026 09:16
Current Prices from BOIRON SA
ExchangeTickerCurrencyLast TradePriceDaily Change
XPAR: Paris
Paris
BOI.PA
EUR
04.02.2026 09:16
29,80 EUR
0,20 EUR
+0,68 %
XFRA: Frankfurt
Frankfurt
BON.F
EUR
04.02.2026 07:03
29,55 EUR
0,15 EUR
+0,51 %
XHAN: Hannover
Hannover
BSAAPE29.HANB
EUR
04.02.2026 07:01
29,55 EUR
0,15 EUR
+0,51 %
XDQU: Quotrix
Quotrix
BSAAPE29.DUSD
EUR
04.02.2026 06:27
29,95 EUR
0,55 EUR
+1,87 %
OTC: UTC
UTC
BOIRF
USD
03.02.2026 21:00
30,00 USD
0,00 USD
XLON: London
London
0DTF.L
EUR
03.02.2026 15:17
29,94 EUR
0,14 EUR
+0,47 %
XDUS: Düsseldorf
Düsseldorf
BSAAPE29.DUSB
EUR
03.02.2026 07:11
29,35 EUR
-0,15 EUR
-0,51 %
Share Float & Liquidity
Free Float 16,50 %
Shares Float 2,87 M
Shares Outstanding 17,36 M
Invested Funds

The following funds have invested in BOIRON SA:

Fund
iShares MSCI EMU Small Cap UCITS ETF EUR (Acc)
Vol. in million
271,39
Percentage (%)
0,03 %
Company Profile for BOIRON SA Share
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
AI Analysis of BOIRON SA
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of BOIRON SA
No AI threads available for this company yet.

Company Data

Name BOIRON SA
Company Boiron S.A.
Website https://www.boiron.fr
Primary Exchange XPAR Paris
WKN 873532
ISIN FR0000061129
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Thierry Boiron
Market Capitalization 521 Mio
Country France
Currency EUR
Employees 2,5 T
Address 2, avenue de l’Ouest Lyonnais, 69510 Messimy
IPO Date 2008-07-29

Ticker Symbols

Name Symbol
Over The Counter BOIRF
Düsseldorf BSAAPE29.DUSB
Frankfurt BON.F
Hannover BSAAPE29.HANB
London 0DTF.L
Paris BOI.PA
Quotrix BSAAPE29.DUSD
More Shares
Investors who hold BOIRON SA also have the following shares in their portfolio:
Nunzia Pharmaceutical Company
Nunzia Pharmaceutical Company Share
SUMIT.M.T.BK 23/28 MTN
SUMIT.M.T.BK 23/28 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026